It is a pharma private limited company based in Thane, Maharashtra, India, established in 2013.
2013 | Thane, Maharashtra, India | ActiveBiorealm Biopharmaceuticals Private Limited, a active private limited company, was established on 03 December 2013 in Thane, Maharashtra, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24299MH2013PTC250679. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹0.10 M.
It upholds a compliant status. Its leadership includes Neeraj Kumar (Director), Suneeta Devi (Director), Bhanwarlal Choudhary (Director). Past directors included Mohammed Sarfraz Khan, Suneeta Devi, Jithendra Reddy Kommula. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Gala 1, Plot No 103 104, Laxmi Industrial Estate, Penkarpada Road, Near Dahisar Check Naka, Thane, Maharashtra, 401107.
U24299MH2013PTC250679
250679
03 December 2013
₹0.10 M
₹0.10 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Biorealm Biopharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Neeraj Kumar | Director | 03 Dec 2013 | Current |
| Suneeta Devi | Director | 25 Apr 2022 | Current |
| Bhanwarlal Choudhary | Director | 03 Dec 2013 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 28 Feb 2018 | Past |
| Pramod Abcsdd | Director | 28 Feb 2018 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Biorealm Biopharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 252.99% increase. The company also saw a slight improvement in profitability, with a 4.3% increase in profit. The company's net worth Soared by an impressive increase of 74.26%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Biorealm Biopharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Biorealm Biopharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Biorealm Biopharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biorealm Biopharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Biorealm Biopharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Biorealm Biopharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Suneeta Devi was appointed as a Director was appointed as a Director on 25 Apr 2022 & has been associated with this company since 3 years 7 months . was recorded as a recent event.
Neeraj Kumar was appointed as a Director was appointed as a Director on 03 Dec 2013 & has been associated with this company since 11 years 11 months . was recorded as a recent event.
The activity Bhanwarlal Choudhary was appointed as a Director was appointed as a Director on 03 Dec 2013 & has been associated with this company since 11 years 11 months . was completed.
The activity Biorealm Biopharmaceuticals Private Limited was registered on 03 Dec 2013 with Roc Mumbai & aged 11 years 11 months as per MCA records. was completed.
The CIN of Biorealm Biopharmaceuticals Private Limited is U24299MH2013PTC250679.
Biorealm Biopharmaceuticals Private Limited is headquartered at Gala 1, Plot No 103 104, Laxmi Industrial Estate, Penkarpada Road, Near Dahisar Check Naka, Thane, Maharashtra, 401107.
Biorealm Biopharmaceuticals Private Limited was incorporated on 03 December 2013.
The current directors of Biorealm Biopharmaceuticals Private Limited are
The primary industry of Biorealm Biopharmaceuticals Private Limited is Trade.
Biorealm Biopharmaceuticals Private Limited is unlisted.
The authorized capital of Biorealm Biopharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹0.10 M.
The compliance status of Biorealm Biopharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX